Memantine Hydrochloride
Product Images NDC 0904-6736

9 FDA label images from Major Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Memantine Hydrochloride (NDC 0904-6736). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (2eba035e 38ce 479d 8dc8 0bfdd2bffbcf 08)

Structural Formula (2eba035e 38ce 479d 8dc8 0bfdd2bffbcf 08)
Chemical structure of memantine hydrochloride showing a cycloalkane framework with an amino group (NH2) and hydrochloride (HCl) attached, along with two methyl (CH3) groups.*
FDA Label Image

Figure 1 (2eba035e 38ce 479d 8dc8 0bfdd2bffbcf 07)

Figure 1 (2eba035e 38ce 479d 8dc8 0bfdd2bffbcf 07)
A line graph depicting mean change from baseline in SIB score over 24 weeks of treatment comparing memantine HCl extended-release 28 mg with placebo, both combined with AChEI. The x-axis shows weeks of treatment from 0 to 24, and the y-axis shows mean change in SIB score from -2 to 5 with error bars. Memantine maintains clinical improvement over 24 weeks, whereas the placebo group shows decline after 12 weeks.*
FDA Label Image

Figure 2 (2eba035e 38ce 479d 8dc8 0bfdd2bffbcf 06)

Figure 2 (2eba035e 38ce 479d 8dc8 0bfdd2bffbcf 06)
A cumulative percentage of patients graph showing the change from baseline in SIB (Severe Impairment Battery) scores. The graph compares memantine hydrochloride extended-release 28 mg treatment with placebo, both in relation to AChEI (acetylcholinesterase inhibitor). Data points for memantine are marked with filled circles, and placebo with open circles.*
FDA Label Image

Figure 3 (2eba035e 38ce 479d 8dc8 0bfdd2bffbcf 05)

Figure 3 (2eba035e 38ce 479d 8dc8 0bfdd2bffbcf 05)
A line chart showing clinical improvement versus decline over 24 weeks of treatment. It compares Memantine HCl Extended-Release 28 mg with placebo, plotting the mean CBIC-Plus Score (y-axis) against weeks of treatment (x-axis). The graph includes error bars and a horizontal line marking the threshold between clinical improvement and decline.*
FDA Label Image

Figure 4 (2eba035e 38ce 479d 8dc8 0bfdd2bffbcf 04)

Figure 4 (2eba035e 38ce 479d 8dc8 0bfdd2bffbcf 04)
A bar chart comparing patient percentages across different CIBIC Plus Rating categories between Memantine HCl Extended-Release 28 mg combined with AChEI and placebo with AChEI. Categories include marked improvement, moderate improvement, minimal improvement, no change, minimal worsening, moderate worsening, and marked worsening.*
FDA Label Image

Logo 1 (2eba035e 38ce 479d 8dc8 0bfdd2bffbcf 03)

Logo 1 (2eba035e 38ce 479d 8dc8 0bfdd2bffbcf 03)
The image shows a blister pack of memantine hydrochloride 7 mg tablets. The label includes a grid pattern on the foil backing with clear visibility of the tablet compartments arranged in a circular pattern. The packaging is associated with Major Pharmaceuticals as the labeler.*
FDA Label Image

Logo 2 (2eba035e 38ce 479d 8dc8 0bfdd2bffbcf 02)

Logo 2 (2eba035e 38ce 479d 8dc8 0bfdd2bffbcf 02)
Memantine Hydrochloride 7 mg/1 oral solution bottle with an orange child-resistant cap. The label shows the product name, strength, dosage form as oral solution, and the labeler Major Pharmaceuticals. The quantity indicated on the label is 100 mL.*
FDA Label Image

7mg Carton Label (2eba035e 38ce 479d 8dc8 0bfdd2bffbcf 01)

7mg Carton Label (2eba035e 38ce 479d 8dc8 0bfdd2bffbcf 01)
Label for Major Pharmaceuticals Memantine Hydrochloride Extended-Release Capsules, 7 mg strength. The label indicates once-daily dosing, a package size of 100 capsules (10 x 10) in unit dose form, and Rx only status. It includes storage information, dispensing instructions, and manufacturer details with a barcode at the bottom.*
FDA Label Image

28mg Carton Label (2eba035e 38ce 479d 8dc8 0bfdd2bffbcf 00)

28mg Carton Label (2eba035e 38ce 479d 8dc8 0bfdd2bffbcf 00)
Major Pharmaceuticals unit dose packaging label for Memantine Hydrochloride Extended-Release Capsules, 28 mg strength. The label states once-daily use, with a package count of 100 capsules (10 x 10). It includes storage instructions, dosage disclaimer, and notes that it is Rx only and intended for institutional use only. The label also displays the NDC 0904-6735-61 and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.